Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-015378-36Phase 3Terminated
Phase 3 trial of glucosamine sulphate in arthralgia, sponsored by Queen Mary University of London. Primary endpoint: Presence or absence of arthralgia at 6 months. Started Nov 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-015378-36.